Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCPK - Delayed Quote USD

Hikma Pharmaceuticals PLC (HKMPF)

26.20
0.00
(0.00%)
At close: April 21 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
3,127,000
3,127,000
2,875,000
2,517,000
2,553,000
Cost of Revenue
1,712,000
1,712,000
1,485,000
1,279,000
1,252,000
Gross Profit
1,415,000
1,415,000
1,390,000
1,238,000
1,301,000
Operating Expense
803,000
803,000
780,000
756,000
704,000
Operating Income
612,000
612,000
610,000
482,000
597,000
Net Non Operating Interest Income Expense
-80,000
-80,000
-80,000
-67,000
-39,000
Pretax Income
455,000
455,000
281,000
233,000
544,000
Tax Provision
93,000
93,000
89,000
42,000
124,000
Net Income Common Stockholders
359,000
359,000
190,000
188,000
421,000
Diluted NI Available to Com Stockholders
359,000
359,000
190,000
188,000
421,000
Basic EPS
1.62
--
0.86
0.84
1.82
Diluted EPS
1.61
--
0.85
0.84
1.81
Basic Average Shares
221,333.25
--
220,862.10
224,000
231,000
Diluted Average Shares
223,493.32
--
222,368.71
225,000
233,000
Total Operating Income as Reported
612,000
612,000
367,000
282,000
582,000
Total Expenses
2,515,000
2,515,000
2,265,000
2,035,000
1,956,000
Net Income from Continuing & Discontinued Operation
359,000
359,000
190,000
188,000
421,000
Normalized Income
404,372
404,372
353,920
309,985
404,788
Interest Income
8,000
8,000
7,000
3,000
1,000
Interest Expense
75,000
75,000
73,000
59,000
56,000
Net Interest Income
-80,000
-80,000
-80,000
-67,000
-39,000
EBIT
530,000
530,000
354,000
292,000
600,000
EBITDA
727,000
727,000
552,000
485,000
744,000
Reconciled Cost of Revenue
1,712,000
1,712,000
1,485,000
1,279,000
1,252,000
Reconciled Depreciation
197,000
197,000
198,000
193,000
144,000
Net Income from Continuing Operation Net Minority Interest
359,000
359,000
190,000
188,000
421,000
Total Unusual Items Excluding Goodwill
-57,000
-57,000
-240,000
-155,000
21,000
Total Unusual Items
-57,000
-57,000
-240,000
-155,000
21,000
Normalized EBITDA
784,000
784,000
792,000
640,000
723,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-11,628
-11,628
-76,080
-33,015
4,788
12/31/2021 - 8/22/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CANQF CanaQuest Medical Corp.
0.0188
0.00%
 
MJRX.CN Global Health Clinics Ltd.
0.0100
0.00%
 
XTXXF Adastra Holdings Ltd.
0.0378
0.00%
 
BKUH Bakhu Holdings, Corp.
0.0150
0.00%
 
CNADF CanadaBis Capital Inc.
0.0625
0.00%
 
VIBEF Vibe Growth Corporation
0.0500
0.00%
 
MJ.CN Maven Brands Inc.
0.0200
0.00%
 
RAMM.CN RAMM Pharma Corp.
0.0150
0.00%
 
MSTH Mystic Holdings, Inc.
0.1010
+243.54%
 
STMH Stem Holdings, Inc.
0.0001
0.00%